{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T03:44:33Z","timestamp":1790912673245,"version":"4.1.0"},"reference-count":155,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2008,4,1]],"date-time":"2008-04-01T00:00:00Z","timestamp":1207008000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Best Practice & Research Clinical Obstetrics & Gynaecology"],"published-print":{"date-parts":[[2008,4]]},"DOI":"10.1016\/j.bpobgyn.2007.10.001","type":"journal-article","created":{"date-parts":[[2007,12,1]],"date-time":"2007-12-01T08:25:38Z","timestamp":1196497538000},"page":"275-306","source":"Crossref","is-referenced-by-count":115,"title":["Endometriosis: current and future medical therapies"],"prefix":"10.1016","volume":"22","author":[{"given":"Paolo","family":"Vercellini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edgardo","family":"Somigliana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Vigan\u00f2","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annalisa","family":"Abbiati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raffaella","family":"Daguati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pier Giorgio","family":"Crosignani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bpobgyn.2007.10.001_bib1","doi-asserted-by":"crossref","first-page":"2679","DOI":"10.1093\/humrep\/del230","article-title":"Reproductive performance, pain recurrence and disease relapse after conservative surgical treatment for endometriosis: the predictive value of the current system","volume":"21","author":"Vercellini","year":"2006","journal-title":"Hum Reprod"},{"key":"10.1016\/j.bpobgyn.2007.10.001_bib2","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1093\/humupd\/dmg030","article-title":"Progestogens for endometriosis: forward to the past","volume":"9","author":"Vercellini","year":"2003","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.bpobgyn.2007.10.001_bib3","first-page":"1077","article-title":"Evidence on endometriosis. Elitism about randomised controlled trials is inappropriate","volume":"321","author":"Redwine","year":"2000","journal-title":"BMJ"},{"key":"10.1016\/j.bpobgyn.2007.10.001_bib4","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1136\/bmj.320.7247.1449","article-title":"Endometriosis","volume":"320","author":"Farquhar","year":"2000","journal-title":"BMJ"},{"key":"10.1016\/j.bpobgyn.2007.10.001_bib5","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0020-7292(00)80034-X","article-title":"Medical management of endometriosis. Number 11, December 1999","volume":"71","author":"The American College of Obstetricians and Gynecologists","year":"2000","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.bpobgyn.2007.10.001_bib6","first-page":"S156","volume":"86","author":"Practice Committee of the American Society for Reproductive Medicine","year":"2006","journal-title":"Endometriosis and infertility. Fertil Steril"},{"key":"10.1016\/j.bpobgyn.2007.10.001_bib7","doi-asserted-by":"crossref","first-page":"2698","DOI":"10.1093\/humrep\/dei135","article-title":"ESHRE guideline for the diagnosis and treatment of endometriosis","volume":"20","author":"Kennedy","year":"2005","journal-title":"Hum Reprod"},{"key":"10.1016\/j.bpobgyn.2007.10.001_bib8","series-title":"The Investigation and Management of Endometriosis","author":"Royal College of Obstetricians and Gynaecologists","year":"2000"},{"key":"10.1016\/j.bpobgyn.2007.10.001_bib9","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3109\/09513598709082692","article-title":"Placebo-controlled comparison of danazol and high-dose medroxyprogesterone acetate in the treatment of endometriosis after conservative surgery","volume":"1","author":"Telimaa","year":"1987","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.bpobgyn.2007.10.001_bib10","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S0015-0282(16)53755-8","article-title":"Lupron depot (leuprolide acetate) for depot suspension in the treatment of endometriosis: a randomized, placebo-controlled, double-blind study","volume":"54","author":"Dlugi","year":"1990","journal-title":"Fertil Steril"},{"key":"10.1016\/j.bpobgyn.2007.10.001_bib11","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/S0015-0282(16)55792-6","article-title":"Buserelin acetate in the treatment of pelvic pain associated with minimal and mild endometriosis: a controlled study","volume":"59","author":"Fedele","year":"1993","journal-title":"Fertil Steril"},{"key":"10.1016\/j.bpobgyn.2007.10.001_bib12","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/S0015-0282(98)00019-3","article-title":"Effects of triptorelin versus placebo on the symptoms of endometriosis","volume":"69","author":"Bergqvist","year":"1998","journal-title":"Fertil Steril"},{"key":"10.1016\/j.bpobgyn.2007.10.001_bib13","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1136\/bmj.323.7304.93","article-title":"Endometriosis","volume":"323","author":"Prentice","year":"2001","journal-title":"BMJ"},{"key":"10.1016\/j.bpobgyn.2007.10.001_bib14","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/S0015-0282(97)00193-3","article-title":"Progestins for symptomatic endometriosis: a critical analysis of the evidence","volume":"68","author":"Vercellini","year":"1997","journal-title":"Fertil Steril"},{"key":"10.1016\/j.bpobgyn.2007.10.001_bib15","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0015-0282(16)56039-7","article-title":"A gonadotropin-releasing hormone agonist versus a low-dose oral contraceptive for pelvic pain associated with endometriosis","volume":"60","author":"Vercellini","year":"1993","journal-title":"Fertil Steril"},{"key":"10.1016\/j.bpobgyn.2007.10.001_bib16","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0301-2115(99)00131-1","article-title":"Estroprogestin vs. gonadotropin agonists plus estroprogestin in the treatment of endometriosis-related pelvic pain: a randomized trial","volume":"88","author":"Parazzini","year":"2000","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.bpobgyn.2007.10.001_bib17","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0029-7844(96)00488-7","article-title":"Extending the duration of active oral contraceptive pills to manage hormone withdrawal symptoms","volume":"89","author":"Sulak","year":"1997","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.bpobgyn.2007.10.001_bib18","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1067\/mob.2002.122988","article-title":"Acceptance of altering the standard 21-day\/7-day oral contraceptive regimen to delay menses and reduce hormone withdrawal symptoms","volume":"186","author":"Sulak","year":"2002","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.bpobgyn.2007.10.001_bib19","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.contraception.2007.01.014","article-title":"Long-term assessment of symptomatology and satisfaction of an extended oral contraceptive regimen","volume":"75","author":"Coffee","year":"2007","journal-title":"Contraception"},{"key":"10.1016\/j.bpobgyn.2007.10.001_bib20","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S1074-3804(96)80004-1","article-title":"Evaluation and management of chronic pelvic pain","volume":"3","author":"Duleba","year":"1996","journal-title":"J Am Assoc Gynecol Laparosc"},{"key":"10.1016\/j.bpobgyn.2007.10.001_bib21","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/S0015-0282(03)00794-5","article-title":"Continuous use of an oral contraceptive for endometriosis-associated recurrent dysmenorrhoea that does not respond to a cyclic pill regimen","volume":"80","author":"Vercellini","year":"2003","journal-title":"Fertil Steril"},{"key":"10.1016\/j.bpobgyn.2007.10.001_bib22","first-page":"24","article-title":"Effect of norethindrone acetate in the treatment of symptomatic endometriosis","volume":"43","author":"Muneyyirci-Delale","year":"1998","journal-title":"Int J Fertil Womens Med"},{"issue":"Suppl C","key":"10.1016\/j.bpobgyn.2007.10.001_bib23","first-page":"41","article-title":"The treatment of endometriosis with dienogest","volume":"35","author":"Moore","year":"1999","journal-title":"Drugs Today"},{"key":"10.1016\/j.bpobgyn.2007.10.001_bib24","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1067\/mob.2002.122852","article-title":"Norethisterone acetate in combination with estrogen: effects on the skeleton and other organs: a review","volume":"187","author":"Riis","year":"2002","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.bpobgyn.2007.10.001_bib25","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1097\/00006250-198906000-00019","article-title":"Comparison of cyproterone acetate and danazol in the treatment of pelvic pain associated with endometriosis","volume":"73","author":"Fedele","year":"1989","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.bpobgyn.2007.10.001_bib26","first-page":"535","article-title":"Treatment of endometriosis with cyproterone acetate. Preliminary report","volume":"27","author":"Moran","year":"1996","journal-title":"Arch Med Res"},{"key":"10.1016\/j.bpobgyn.2007.10.001_bib27","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/S0015-0282(01)02951-X","article-title":"Cyproterone acetate versus a continuous monophasic oral contraceptive in the treatment of recurrent pelvic pain after conservative surgery for symptomatic endometriosis","volume":"77","author":"Vercellini","year":"2002","journal-title":"Fertil Steril"},{"key":"10.1016\/j.bpobgyn.2007.10.001_bib28","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1016\/S0002-9378(94)05017-9","article-title":"Long-acting injectable contraception with depot medroxyprogesterone acetate","volume":"170","author":"Kaunitz","year":"1994","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.bpobgyn.2007.10.001_bib29","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1001\/jama.1995.03520340055036","article-title":"Depot medroxyprogesterone acetate and breast cancer: a pooled analysis of the World Health Organization and New Zealand Studies","volume":"273","author":"Skegg","year":"1995","journal-title":"JAMA"},{"key":"10.1016\/j.bpobgyn.2007.10.001_bib30","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1136\/bmj.303.6793.13","article-title":"Bone density in women receiving depot medroxyprogesterone acetate for contraception","volume":"303","author":"Cundy","year":"1991","journal-title":"BMJ"},{"key":"10.1016\/j.bpobgyn.2007.10.001_bib31","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1097\/00001648-200209000-00015","article-title":"Injectable hormone contraception and bone density: results from a prospective study","volume":"13","author":"Scholes","year":"2002","journal-title":"Epidemiology"},{"key":"10.1016\/j.bpobgyn.2007.10.001_bib32","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1016\/j.fertnstert.2004.04.064","article-title":"Bone mineral density changes over two years in first-time users of depot medroxyprogesterone acetate","volume":"82","author":"Clark","year":"2004","journal-title":"Fertil Steril"},{"key":"10.1016\/j.bpobgyn.2007.10.001_bib33","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.contraception.2006.04.003","article-title":"Effect of long-term use of depot medroxyprogesterone acetate as hormonal contraceptive on bone mineral density and biochemical markers of bone remodeling","volume":"74","author":"Shaarawy","year":"2006","journal-title":"Contraception"},{"key":"10.1016\/j.bpobgyn.2007.10.001_bib34","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/S0002-9378(96)70152-7","article-title":"Depot medroxyprogesterone acetate versus an oral contraceptive combined with very-low-dose danazol for long-term treatment of pelvic pain associated with endometriosis","volume":"175","author":"Vercellini","year":"1996","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.bpobgyn.2007.10.001_bib35","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1093\/humrep\/dei290","article-title":"Subcutaneous depot medroxyprogesterone acetate versus leuprolide acetate in the treatment of endometriosis-associated pain","volume":"21","author":"Crosignani","year":"2006","journal-title":"Hum Reprod"},{"key":"10.1016\/j.bpobgyn.2007.10.001_bib36","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.fertnstert.2005.07.1315","article-title":"Subcutaneous injection of depot medroxyprogesterone acetate compared with leuprolide acetate in the treatment of endometriosis-associated pain","volume":"85","author":"Schlaff","year":"2006","journal-title":"Fertil Steril"},{"key":"10.1016\/j.bpobgyn.2007.10.001_bib37","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1093\/molehr\/4.12.1110","article-title":"The effect of intrauterine levonorgestrel use on the expression of C-Jun, oestrogen receptors, progesterone receptors and Ki-67 in human endometrium","volume":"4","author":"Salmi","year":"1998","journal-title":"Mol Hum Reprod"},{"key":"10.1016\/j.bpobgyn.2007.10.001_bib38","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1093\/humrep\/deh004","article-title":"The evaluation of the effectiveness of an intrauterine-administered progestogen (levonorgestrel) in the symptomatic treatment of endometriosis and in the staging of the disease","volume":"19","author":"Lockhat","year":"2004","journal-title":"Hum Reprod"},{"key":"10.1016\/j.bpobgyn.2007.10.001_bib39","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1111\/j.1471-0528.1990.tb16249.x","article-title":"Assessment of menstrual blood loss using a pictorial chart","volume":"97","author":"Higham","year":"1990","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.bpobgyn.2007.10.001_bib40","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1093\/humrep\/deh650","article-title":"The efficacy, side-effects and continuation rates in women with symptomatic endometriosis undergoing treatment with an intra-uterine administered progestogen (levonorgestrel): a 3 year follow-up","volume":"20","author":"Lockhat","year":"2005","journal-title":"Hum Reprod"},{"key":"10.1016\/j.bpobgyn.2007.10.001_bib41","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1093\/humrep\/deh869","article-title":"Randomized clinical trial of a levonorgestrel-releasing intrauterine system and a depot GnRH analogue for the treatment of chronic pelvic pain in women with endometriosis","volume":"20","author":"Petta","year":"2005","journal-title":"Hum Reprod"},{"key":"10.1016\/j.bpobgyn.2007.10.001_bib42","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0015-0282(99)00291-5","article-title":"A levonorgestrel-releasing intrauterine system for the treatment of dysmenorrhoea associated with endometriosis: a pilot study","volume":"72","author":"Vercellini","year":"1999","journal-title":"Fertil Steril"},{"key":"10.1016\/j.bpobgyn.2007.10.001_bib43","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S0015-0282(03)00608-3","article-title":"Comparison of a levonorgestrel-releasing intrauterine device versus expectant management after conservative surgery for symptomatic endometriosis: a pilot study","volume":"80","author":"Vercellini","year":"2003","journal-title":"Fertil Steril"},{"key":"10.1016\/j.bpobgyn.2007.10.001_bib44","doi-asserted-by":"crossref","first-page":"S39","DOI":"10.1016\/j.ajog.2004.01.064","article-title":"Recent developments in hormone delivery system","volume":"190","author":"Shulman","year":"2004","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.bpobgyn.2007.10.001_bib45","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/S0015-0282(99)00367-2","article-title":"Chocolate cysts from ovarian follicles","volume":"72","author":"Jain","year":"1999","journal-title":"Fertil Steril"},{"key":"10.1016\/j.bpobgyn.2007.10.001_bib46","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1097\/01.gco.0000175353.03061.7f","article-title":"The role of the levonorgestrel-releasing intrauterine device in the management of symptomatic endometriosis","volume":"17","author":"Vercellini","year":"2005","journal-title":"Curr Opin Obstet Gynecol"},{"key":"10.1016\/j.bpobgyn.2007.10.001_bib47","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1016\/j.ajog.2003.10.698","article-title":"Long-term follow-up after conservative surgery for rectovaginal endometriosis","volume":"190","author":"Fedele","year":"2004","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.bpobgyn.2007.10.001_bib48","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1111\/j.1471-0528.2004.00093.x","article-title":"Pain, quality of life and complications following the radical resection of rectovaginal endometriosis","volume":"111","author":"Ford","year":"2004","journal-title":"BJOG"},{"key":"10.1016\/j.bpobgyn.2007.10.001_bib49","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S1074-3804(05)60190-9","article-title":"Deep endometriosis: definition, pathogenesis, and clinical management","volume":"11","author":"Vercellini","year":"2004","journal-title":"J Am Assoc Gynecol Laparosc"},{"key":"10.1016\/j.bpobgyn.2007.10.001_bib50","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/S0015-0282(00)01759-3","article-title":"Use of a levonorgestrel-releasing intrauterine device in the treatment of rectovaginal endometriosis","volume":"75","author":"Fedele","year":"2001","journal-title":"Fertil Steril"},{"key":"10.1016\/j.bpobgyn.2007.10.001_bib51","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1016\/j.fertnstert.2005.03.083","article-title":"Treatment of symptomatic rectovaginal endometriosis with an estrogen-progestogen combination versus low-dose norethindrone acetate","volume":"84","author":"Vercellini","year":"2005","journal-title":"Fertil Steril"},{"key":"10.1016\/j.bpobgyn.2007.10.001_bib52","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1067\/mob.2003.408","article-title":"Endometriosis and ovarian cancer: thoughts on shared pathophysiology","volume":"189","author":"Ness","year":"2003","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.bpobgyn.2007.10.001_bib53","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1093\/humupd\/dmi037","article-title":"Molecular mechanisms and biological plausibility underlying the malignant transformation of endometriosis: a critical analysis","volume":"12","author":"Vigan\u00f2","year":"2006","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.bpobgyn.2007.10.001_bib54","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.ygyno.2005.11.033","article-title":"Association between endometriosis and cancer: a comprehensive review and a critical analysis of clinical and epidemiological evidence","volume":"101","author":"Somigliana","year":"2006","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.bpobgyn.2007.10.001_bib55","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.fertnstert.2006.11.180","article-title":"Bias versus causality: interpreting recent evidence of association between endometriosis and ovarian cancer","volume":"88","author":"Vigan\u00f2","year":"2007","journal-title":"Fertil Steril"},{"key":"10.1016\/j.bpobgyn.2007.10.001_bib56","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.ajog.2004.03.035","article-title":"Oral contraceptive use, reproductive history, and risk of epithelial ovarian cancer in women with and without endometriosis","volume":"191","author":"Modugno","year":"2004","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.bpobgyn.2007.10.001_bib57","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1080\/13697130600868711","article-title":"Hormone replacement therapy in women with past history of endometriosis","volume":"9","author":"Soliman","year":"2006","journal-title":"Climateric"},{"key":"10.1016\/j.bpobgyn.2007.10.001_bib58","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0378-5122(99)00032-8","article-title":"Comparison of transdermal estradiol and tibolone for the treatment of oophorectomized women with deep residual endometriosis","volume":"32","author":"Fedele","year":"1999","journal-title":"Maturitas"},{"key":"10.1016\/j.bpobgyn.2007.10.001_bib59","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/S0015-0282(16)58096-0","article-title":"The effect of add-back treatment with tibolone (Livial) on patients treated with the gonadotropin-releasing hormone agonist triptorelin (Decapeptyl)","volume":"65","author":"Lindsay","year":"1996","journal-title":"Fertil Steril"},{"key":"10.1016\/j.bpobgyn.2007.10.001_bib60","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1093\/humupd\/6.5.505","article-title":"Direct ovarian effects and safety aspects of GnRH agonists and antagonists","volume":"6","author":"Janssens","year":"2000","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.bpobgyn.2007.10.001_bib61","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1677\/joe.1.05883","article-title":"Hypothalamic hormones a.k.a. hypothalamic releasing factors","volume":"184","author":"Guillemin","year":"2005","journal-title":"J Endocrinol"},{"key":"10.1016\/j.bpobgyn.2007.10.001_bib62","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1016\/S0140-6736(01)06797-6","article-title":"Gonadotropin-releasing-hormone-receptor antagonists","volume":"358","author":"Huirne","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.bpobgyn.2007.10.001_bib63","doi-asserted-by":"crossref","first-page":"83","DOI":"10.2165\/00024677-200403020-00003","article-title":"Optimizing gonadotropin-releasing hormone agonist therapy in women with endometriosis","volume":"3","author":"Olive","year":"2004","journal-title":"Treat Endocrinol"},{"key":"10.1016\/j.bpobgyn.2007.10.001_bib64","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.jmig.2006.07.007","article-title":"GnRH analogs: options for endometriosis-associated pain treatment","volume":"13","author":"Batzer","year":"2006","journal-title":"J Minim Invasive Gynecol"},{"key":"10.1016\/j.bpobgyn.2007.10.001_bib65","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD001019.pub2","article-title":"Modern combined oral contraceptives for pain associated with endometriosis","volume":"3","author":"Davis","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.bpobgyn.2007.10.001_bib66","article-title":"Gonadotrophin-releasing hormone analogues for pain associated with endometriosis","volume":"3","author":"Prentice","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.bpobgyn.2007.10.001_bib67","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1111\/j.1471-0528.1998.tb10146.x","article-title":"GnRH agonists and add-back therapy: is there a perfect combination?","volume":"105","author":"Pickersgill","year":"1998","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.bpobgyn.2007.10.001_bib68","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.fertnstert.2005.12.030","article-title":"Treatment with leuprolide acetate and hormonal add-back for up to 10 years in stage IV endometriosis patients with chronic pelvic pain","volume":"86","author":"Bedaiwy","year":"2006","journal-title":"Fertil Steril"},{"key":"10.1016\/j.bpobgyn.2007.10.001_bib69","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/S0015-0282(16)55791-4","article-title":"Gonadotropin-releasing hormone analogues for the treatment of endometriosis: long-term follow-up","volume":"59","author":"Waller","year":"1993","journal-title":"Fertil Steril"},{"key":"10.1016\/j.bpobgyn.2007.10.001_bib70","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/0002-9378(92)91706-G","article-title":"Hormone treatment of endometriosis: the estrogen threshold hypothesis","volume":"166","author":"Barbieri","year":"1992","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.bpobgyn.2007.10.001_bib71","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0378-5122(99)00076-6","article-title":"Estrogen with interrupted progestin HRT: a review of experimental and clinical studies","volume":"34","author":"Casper","year":"2000","journal-title":"Maturitas"},{"key":"10.1016\/j.bpobgyn.2007.10.001_bib72","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1097\/00042192-200207000-00004","article-title":"Prevention of bone loss and hypoestrogenic symptoms by estrogen and interrupted progestogen add-back in long-term GnRH-agonist down-regulated patients with endometriosis and premestrual syndrome","volume":"9","author":"Mitwally","year":"2002","journal-title":"Menopause"},{"key":"10.1016\/j.bpobgyn.2007.10.001_bib73","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/S0029-7844(02)01945-2","article-title":"Prolonged GnRH agonist and add-back therapy for symptomatic endometriosis: long-term follow-up","volume":"99","author":"Surrey","year":"2002","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.bpobgyn.2007.10.001_bib74","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1016\/j.fertnstert.2004.03.062","article-title":"Add-back therapy in the treatment of endometriosis-associated pain","volume":"82","author":"Zupi","year":"2004","journal-title":"Fertil Steril"},{"key":"10.1016\/j.bpobgyn.2007.10.001_bib75","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1080\/09513590410001725495","article-title":"Gonadotropin-releasing hormone agonists for prevention of postoperative adhesions: an overview","volume":"19","author":"Schindler","year":"2004","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.bpobgyn.2007.10.001_bib76","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0889-8545(02)00059-1","article-title":"Endometriosis: preoperative and postoperative medical treatment","volume":"30","author":"Vercellini","year":"2003","journal-title":"Obstet Gynecol Clin North Am"},{"key":"10.1016\/j.bpobgyn.2007.10.001_bib77","article-title":"Pre and post operative medical therapy for endometriosis surgery","volume":"3","author":"Yap","year":"2004","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.bpobgyn.2007.10.001_bib78","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1016\/0002-9378(94)90133-3","article-title":"Postsurgical medical treatment of advanced endometriosis: results of a randomized clinical trial","volume":"171","author":"Parazzini","year":"1994","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.bpobgyn.2007.10.001_bib79","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/S0015-0282(97)00360-9","article-title":"Use of nafarelin versus placebo after reductive laparoscopic surgery for endometriosis","volume":"68","author":"Hornstein","year":"1997","journal-title":"Fertil Steril"},{"key":"10.1016\/j.bpobgyn.2007.10.001_bib80","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1111\/j.1471-0528.1999.tb08366.x","article-title":"A gonadotrophin-releasing hormone agonist compared with expectant management after conservative surgery for symptomatic endometriosis","volume":"106","author":"Vercellini","year":"1999","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.bpobgyn.2007.10.001_bib81","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1093\/humrep\/16.11.2399","article-title":"Post-operative GnRH analogue treatment after conservative surgery for symptomatic endometriosis stage III\/IV: a randomized controlled trial","volume":"16","author":"Busacca","year":"2001","journal-title":"Hum Reprod"},{"key":"10.1016\/j.bpobgyn.2007.10.001_bib82","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/S0015-0282(01)03270-8","article-title":"Dienogest is as effective as triptorelin in the treatment of endometriosis after laparoscopic surgery: results of a prospective, multicenter, randomized study","volume":"77","author":"Cosson","year":"2002","journal-title":"Fertil Steril"},{"key":"10.1016\/j.bpobgyn.2007.10.001_bib83","article-title":"A randomized study comparing triptorelin or expectant management following conservative laparoscopic surgery for symptomatic stage III\u2013IV endometriosis","author":"Loverro","year":"2007","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.bpobgyn.2007.10.001_bib84","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1136\/bmj.39073.736829.BE","article-title":"Endometriosis","volume":"334","author":"Farquhar","year":"2007","journal-title":"BMJ"},{"key":"10.1016\/j.bpobgyn.2007.10.001_bib85","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1056\/NEJM198802253180805","article-title":"Administration of nasal nafarelin as compared with oral danazol for endometriosis. A multicenter double-blind comparative clinical trial","volume":"318","author":"Henzl","year":"1988","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bpobgyn.2007.10.001_bib86","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/0002-9378(89)90739-4","article-title":"Buserelin versus danazol in the treatment of endometriosis-associated infertility","volume":"161","author":"Fedele","year":"1989","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.bpobgyn.2007.10.001_bib87","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1111\/j.1479-828X.1991.tb01807.x","article-title":"A comparative treatment trial of endometriosis using the gonadotrophin-releasing hormone agonist, nafarelin, and the synthetic steroid, danazol","volume":"31","author":"Fraser","year":"1991","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"10.1016\/j.bpobgyn.2007.10.001_bib88","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1016\/0002-9378(92)91602-7","article-title":"Buserelin acetate versus expectant management in the treatment of infertility associated with minimal or mild endometriosis: a randomized clinical trial","volume":"166","author":"Fedele","year":"1992","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.bpobgyn.2007.10.001_bib89","first-page":"523","article-title":"Depot leuprorelin acetate versus danazol in the treatment of infertile women with symptomatic endometriosis","volume":"23","author":"Rotondi","year":"2002","journal-title":"Eur J Gynaecol Oncol"},{"key":"10.1016\/j.bpobgyn.2007.10.001_bib90","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1093\/oxfordjournals.humrep.a137114","article-title":"The value of pre-treatment with gonadotrophin releasing hormone (GnRH) analogue in IVF-ET therapy of severe endometriosis","volume":"5","author":"Dicker","year":"1990","journal-title":"Hum Reprod"},{"key":"10.1016\/j.bpobgyn.2007.10.001_bib91","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD004635.pub2","article-title":"Long-term pituitary down regulation before in vitro fertilization (IVF) for women with endometriosis","volume":"1","author":"Sallam","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.bpobgyn.2007.10.001_bib92","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/S0015-0282(16)54906-1","article-title":"The impact of long-term gonadotropin-releasing hormone analogue treatment on preclinical abortions in patients with severe endometriosis undergoing in vitro fertilization-embryo transfer","volume":"57","author":"Dicker","year":"1992","journal-title":"Fertil Steril"},{"key":"10.1016\/j.bpobgyn.2007.10.001_bib93","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/S0015-0282(02)03338-1","article-title":"Increased pregnancy rates after ultralong postoperative therapy with gonadotropin-releasing hormone analogs in patients with endometriosis","volume":"78","author":"Rickes","year":"2002","journal-title":"Fertil Steril"},{"key":"10.1016\/j.bpobgyn.2007.10.001_bib94","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/S0015-0282(02)03373-3","article-title":"Effect of prolonged gonadotropin-releasing hormone agonist therapy on the outcome of in vitro fertilization-embryo transfer in patients with endometriosis","volume":"78","author":"Surrey","year":"2002","journal-title":"Fertil Steril"},{"key":"10.1016\/j.bpobgyn.2007.10.001_bib95","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1093\/humupd\/dmi035","article-title":"Should endometriomas be treated before IVF-ICSI cycles?","volume":"12","author":"Somigliana","year":"2006","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.bpobgyn.2007.10.001_bib96","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1093\/humupd\/6.4.322","article-title":"The LHRH antagonist cetrorelix: a review","volume":"6","author":"Reissmann","year":"2000","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.bpobgyn.2007.10.001_bib97","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1097\/00001703-200106000-00002","article-title":"Gonadotropin-releasing hormone antagonist: how good is the new hope?","volume":"13","author":"Albano","year":"2001","journal-title":"Curr Opin Obstet Gynecol"},{"issue":"Suppl 1","key":"10.1016\/j.bpobgyn.2007.10.001_bib98","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/S1472-6483(11)60220-4","article-title":"Will GnRH antagonists assist in the treatment of benign gynaecological diseases?","volume":"5","author":"Felberbaum","year":"2002","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.bpobgyn.2007.10.001_bib99","doi-asserted-by":"crossref","first-page":"3017","DOI":"10.2174\/0929867043363983","article-title":"Non-peptidic GnRH receptor antagonists","volume":"11","author":"Armer","year":"2004","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.bpobgyn.2007.10.001_bib100","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1517\/13543784.14.9.1085","article-title":"New developments in the use of peptide gonadotropin-releasing hormone antagonists versus agonists","volume":"14","author":"Schultze-Mosgau","year":"2005","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1016\/j.bpobgyn.2007.10.001_bib101","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1517\/14656566.7.15.2155","article-title":"Cetrorelix in the treatment of female infertility and endometriosis","volume":"7","author":"Finas","year":"2006","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.bpobgyn.2007.10.001_bib102","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/S1472-6483(10)61590-8","article-title":"Use of GnRH antagonists in the treatment of endometriosis","volume":"5","author":"Kupker","year":"2002","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.bpobgyn.2007.10.001_bib103","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/j.fertnstert.2006.12.046","article-title":"GnRH agonist and antagonist protocols for stage I\u2013II endometriosis and endometrioma in vitro fertilization\/intracytoplasmic sperm injection cycles","volume":"88","author":"Pabuccu","year":"2007","journal-title":"Fertil Steril"},{"key":"10.1016\/j.bpobgyn.2007.10.001_bib104","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1210\/en.2006-1213","article-title":"Pharmacological characterization of a novel nonpeptide antagonist of the human gonadotropin-releasing hormone receptor, NBI-42902","volume":"148","author":"Struthers","year":"2007","journal-title":"Endocrinology"},{"key":"10.1016\/j.bpobgyn.2007.10.001_bib105","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1093\/humupd\/dmi049","article-title":"Advances in the management of endometriosis: an update for clinicians","volume":"12","author":"Crosignani","year":"2006","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.bpobgyn.2007.10.001_bib106","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD000068","article-title":"Danazol for pelvic pain associated with endometriosis","volume":"4","author":"Selak","year":"2001","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.bpobgyn.2007.10.001_bib107","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1093\/humrep\/14.5.1335","article-title":"Effects of 3 month therapy with danazol after laparoscopic surgery for stage III\/IV endometriosis: a randomized study","volume":"14","author":"Bianchi","year":"1999","journal-title":"Hum Reprod"},{"key":"10.1016\/j.bpobgyn.2007.10.001_bib108","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.jmig.2006.06.008","article-title":"The role of progestins in treating the pain of endometriosis","volume":"13","author":"Surrey","year":"2006","journal-title":"J Minim Invasive Gynecol"},{"key":"10.1016\/j.bpobgyn.2007.10.001_bib109","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/S0015-0282(16)60666-0","article-title":"Gestrinone versus danazol in the treatment of endometriosis","volume":"51","author":"Fedele","year":"1989","journal-title":"Fertil Steril"},{"key":"10.1016\/j.bpobgyn.2007.10.001_bib110","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/S0015-0282(16)58682-8","article-title":"Gestrinone versus a gonadotropin-releasing hormone agonist for the treatment of pelvic pain associated with endometriosis: a multicenter, randomized, double-blind study","volume":"66","author":"Gestrinone Italian Study Group","year":"1996","journal-title":"Fertil Steril"},{"key":"10.1016\/j.bpobgyn.2007.10.001_bib111","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0889-8545(02)00052-9","article-title":"Pathogenesis of endometriosis","volume":"30","author":"Seli","year":"2003","journal-title":"Obstet Gynecol Clin North Am"},{"key":"10.1016\/j.bpobgyn.2007.10.001_bib112","series-title":"Understanding and Managing Endometriosis: Advances in Research and Practice","first-page":"139","article-title":"Aromatase expression in endometriosis: biology and clinical perspectives","author":"Bulun","year":"1998"},{"key":"10.1016\/j.bpobgyn.2007.10.001_bib113","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1093\/humupd\/6.5.413","article-title":"Molecular basis for treating endometriosis with aromatase inhibitors","volume":"6","author":"Bulun","year":"2000","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.bpobgyn.2007.10.001_bib114","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1081\/CNV-120014882","article-title":"Anti-tumor effects of letrozole","volume":"20","author":"Miller","year":"2002","journal-title":"Cancer Invest"},{"key":"10.1016\/j.bpobgyn.2007.10.001_bib115","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1177\/107327480200900606","article-title":"Aromatase inhibitors in breast cancer: an update","volume":"9","author":"Lake","year":"2002","journal-title":"Cancer Control"},{"key":"10.1016\/j.bpobgyn.2007.10.001_bib116","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/S0015-0282(02)03233-8","article-title":"Endometriosis: novel etiopathogenetic concepts and clinical perspectives","volume":"78","author":"Vignali","year":"2002","journal-title":"Fertil Steril"},{"key":"10.1016\/j.bpobgyn.2007.10.001_bib117","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.fertnstert.2003.09.029","article-title":"Treatment of endometriosis and chronic pelvic pain with letrozole and norethindrone acetate: a pilot study","volume":"81","author":"Ailawadi","year":"2004","journal-title":"Fertil Steril"},{"key":"10.1016\/j.bpobgyn.2007.10.001_bib118","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.fertnstert.2005.02.018","article-title":"Anastrazole and oral contraceptives: a novel treatment for endometriosis","volume":"84","author":"Amsterdam","year":"2005","journal-title":"Fertil Steril"},{"key":"10.1016\/j.bpobgyn.2007.10.001_bib119","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1093\/humrep\/deh035","article-title":"The effects of post-surgical administration of goserelin plus anastrozole compared to goserelin alone in patients with severe endometriosis: a prospective randomized trial","volume":"19","author":"Soysal","year":"2004","journal-title":"Hum Reprod"},{"key":"10.1016\/j.bpobgyn.2007.10.001_bib120","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1111\/j.1600-0897.1997.tb00319.x","article-title":"Peritoneal cell immunity and endometriosis","volume":"38","author":"Ho","year":"1997","journal-title":"Am J Reprod Immunol"},{"key":"10.1016\/j.bpobgyn.2007.10.001_bib121","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S0889-8545(05)70304-1","article-title":"Basic research in endometriosis","volume":"24","author":"Sharpe-Timms","year":"1997","journal-title":"Obstet Gynecol Clin N Am"},{"key":"10.1016\/j.bpobgyn.2007.10.001_bib122","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1093\/humupd\/4.5.719","article-title":"Paracrine changes in the peritoneal environment of women with endometriosis","volume":"4","author":"Kupker","year":"1998","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.bpobgyn.2007.10.001_bib123","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0015-0282(00)01630-7","article-title":"Immunobiology of endometriosis","volume":"75","author":"Lebovic","year":"2001","journal-title":"Fertil Steril"},{"key":"10.1016\/j.bpobgyn.2007.10.001_bib124","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1006\/smim.1998.0138","article-title":"Role of early cytokines, including alpha and beta interferons (IFN-alpha\/beta), in innate and adaptive immune responses to viral infections","volume":"10","author":"Biron","year":"1998","journal-title":"Semin Immunol"},{"key":"10.1016\/j.bpobgyn.2007.10.001_bib125","first-page":"1552","article-title":"Selective modulation of elements of the immune system by low molecular weight nucleosides","volume":"274","author":"Goodman","year":"1995","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.bpobgyn.2007.10.001_bib126","first-page":"183","article-title":"Investigating the role of immunomodulation for colon cancer prevention: results of an in vivo dose escalation trial of levamisole with immunologic endpoints","volume":"25","author":"Holcombe","year":"2001","journal-title":"Cancer Detect Prev"},{"key":"10.1016\/j.bpobgyn.2007.10.001_bib127","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1046\/j.1365-4362.2001.01190.x","article-title":"Levamisole: a safe and economical weapon against pediculosis","volume":"40","author":"Namazi","year":"2001","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.bpobgyn.2007.10.001_bib128","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/S0015-0282(99)00087-4","article-title":"Intraperitoneal and subcutaneous treatment of experimental endometriosis with recombinant human interferon-alpha-2b in a murine model","volume":"71","author":"Ingelmo","year":"1999","journal-title":"Fertil Steril"},{"key":"10.1016\/j.bpobgyn.2007.10.001_bib129","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0015-0282(99)00157-0","article-title":"Regression of endometrial explants in a rat model of endometriosis treated with the immune modulators loxoribine and levamisole","volume":"72","author":"Keenan","year":"1999","journal-title":"Fertil Steril"},{"key":"10.1016\/j.bpobgyn.2007.10.001_bib130","doi-asserted-by":"crossref","first-page":"2944","DOI":"10.1093\/humrep\/14.12.2944","article-title":"Endometrial ability to implant in ectopic sites can be prevented by interleukin-12 in a murine model of endometriosis","volume":"14","author":"Somigliana","year":"1999","journal-title":"Hum Reprod"},{"key":"10.1016\/j.bpobgyn.2007.10.001_bib131","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S0029-7844(01)01395-3","article-title":"Effect of interferon alpha-2b on endometrioma cells in vitro","volume":"98","author":"Badawy","year":"2001","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.bpobgyn.2007.10.001_bib132","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0015-0282(01)01878-7","article-title":"Treating endometriosis as an autoimmune disease","volume":"76","author":"Nothnick","year":"2001","journal-title":"Fertil Steril"},{"key":"10.1016\/j.bpobgyn.2007.10.001_bib133","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1034\/j.1600-0897.2002.01101.x","article-title":"Increased expression of cyclooxygenase-2 in local lesions of endometriosis patients","volume":"48","author":"Chishima","year":"2002","journal-title":"Am J Reprod Immunol"},{"key":"10.1016\/j.bpobgyn.2007.10.001_bib134","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1016\/j.fertnstert.2004.03.059","article-title":"Cyclooxygenase-2 expression in deep endometriosis and matched eutopic endometrium","volume":"82","author":"Matsuzaki","year":"2004","journal-title":"Fertil Steril"},{"key":"10.1016\/j.bpobgyn.2007.10.001_bib135","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.ejogrb.2004.02.007","article-title":"The treatment with a COX-2 specific inhibitor is effective in the management of pain related to endometriosis","volume":"116","author":"Cobellis","year":"2004","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"Suppl 1","key":"10.1016\/j.bpobgyn.2007.10.001_bib136","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.fertnstert.2003.09.034","article-title":"Efficacy of anti-tumor necrosis factor therapy in the treatment of spontaneous endometriosis in baboons","volume":"81","author":"Barrier","year":"2004","journal-title":"Fertil Steril"},{"key":"10.1016\/j.bpobgyn.2007.10.001_bib137","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1093\/humupd\/4.5.736","article-title":"Angiogenesis: a new theory for endometriosis","volume":"4","author":"Healy","year":"1998","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.bpobgyn.2007.10.001_bib138","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1093\/humupd\/6.1.45","article-title":"Vascular endothelial growth factor and endometriotic angiogenesis","volume":"6","author":"McLaren","year":"2000","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.bpobgyn.2007.10.001_bib139","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1093\/humrep\/13.6.1686","article-title":"Vascular endothelial growth factor (VEGF) in endometriosis","volume":"13","author":"Donnez","year":"1998","journal-title":"Hum Reprod"},{"key":"10.1016\/j.bpobgyn.2007.10.001_bib140","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1093\/oxfordjournals.humrep.a019023","article-title":"Vascular endothelial growth factor (VEGF) concentrations are elevated in peritoneal fluid of women with endometriosis","volume":"11","author":"McLaren","year":"1996","journal-title":"Hum Reprod"},{"key":"10.1016\/j.bpobgyn.2007.10.001_bib141","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/S0015-0282(02)03187-4","article-title":"Expression of vascular endothelial growth factor and thrombospondin-1 mRNA in patients with endometriosis","volume":"78","author":"Tan","year":"2002","journal-title":"Fertil Steril"},{"key":"10.1016\/j.bpobgyn.2007.10.001_bib142","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1093\/humupd\/dmi002","article-title":"Selective progesterone receptor modulators and progesterone antagonists: mechanisms of action and clinical applications","volume":"11","author":"Chabbert-Buffet","year":"2005","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.bpobgyn.2007.10.001_bib143","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1210\/er.2005-0001","article-title":"Selective progesterone receptor modulator development and use in the treatment of leiomyomata and endometriosis","volume":"26","author":"Chwalisz","year":"2005","journal-title":"Endocr Rev"},{"key":"10.1016\/j.bpobgyn.2007.10.001_bib144","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.bpobgyn.2004.03.005","article-title":"New medical treatments for endometriosis","volume":"18","author":"Olive","year":"2004","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"10.1016\/j.bpobgyn.2007.10.001_bib145","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1097\/01.ogx.0000189153.87365.dc","article-title":"Future perspectives in the medical treatment of endometriosis","volume":"60","author":"Ferrero","year":"2005","journal-title":"Obstet Gynecol Surv"},{"key":"10.1016\/j.bpobgyn.2007.10.001_bib146","doi-asserted-by":"crossref","first-page":"S83","DOI":"10.1016\/j.fertnstert.2004.07.212","article-title":"Treatment of endometriosis with the novel selective progesterone receptor modulator (SPRM) asoprisnil","volume":"82","author":"Chwalisz","year":"2004","journal-title":"Fertil Steril"},{"key":"10.1016\/j.bpobgyn.2007.10.001_bib147","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/S0015-0282(01)02736-4","article-title":"Validation study of nonsurgical diagnosis of endometriosis","volume":"76","author":"Eskenazi","year":"2001","journal-title":"Fertil Steril"},{"key":"10.1016\/j.bpobgyn.2007.10.001_bib148","doi-asserted-by":"crossref","first-page":"e191","DOI":"10.1371\/journal.pmed.0030191","article-title":"The fight against disease mongering: generating knowledge for action","volume":"3","author":"Moynihan","year":"2006","journal-title":"PLoS Med"},{"key":"10.1016\/j.bpobgyn.2007.10.001_bib149","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1056\/NEJM199110173251620","article-title":"Importance of the lay press in the transmission of medical knowledge to the scientific community","volume":"325","author":"Phillips","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bpobgyn.2007.10.001_bib150","first-page":"4","article-title":"Redefining endometriosis in the modern era","volume":"2","author":"Redwine","year":"2005","journal-title":"Leadership Medica"},{"key":"10.1016\/j.bpobgyn.2007.10.001_bib151","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1001\/jama.282.24.2313","article-title":"Informed decision making in outpatient practice: time to get back to basics","volume":"282","author":"Braddock","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.bpobgyn.2007.10.001_bib152","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0749-3797(99)00097-5","article-title":"Shared decision making in clinical medicine: past research and future directions","volume":"17","author":"Frosch","year":"1999","journal-title":"Am J Prev Med"},{"key":"10.1016\/j.bpobgyn.2007.10.001_bib153","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1136\/bmj.323.7311.466","article-title":"A key medical decision maker: the patient","volume":"323","author":"Deyo","year":"2001","journal-title":"BMJ"},{"key":"10.1016\/j.bpobgyn.2007.10.001_bib154","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/S1049-3867(01)00102-5","article-title":"Patient-centered decision making: empowering women to make informed choices","volume":"11","author":"Coulter","year":"2001","journal-title":"Womens Health Issues"},{"key":"10.1016\/j.bpobgyn.2007.10.001_bib155","unstructured":"Vercellini P, Somigliana E, Daguati R et al. Postoperative oral contraceptive exposure and risk of endometrioma recurrence. Am J Obstet Gynecol 2007; in press."}],"container-title":["Best Practice & Research Clinical Obstetrics & Gynaecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521693407001642?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521693407001642?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,5]],"date-time":"2019-05-05T11:51:18Z","timestamp":1557057078000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521693407001642"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,4]]},"references-count":155,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008,4]]}},"alternative-id":["S1521693407001642"],"URL":"https:\/\/doi.org\/10.1016\/j.bpobgyn.2007.10.001","relation":{},"ISSN":["1521-6934"],"issn-type":[{"value":"1521-6934","type":"print"}],"subject":[],"published":{"date-parts":[[2008,4]]}}}